bm|t successfully facilitated the acquisition of its portfolio company Spleenlab by Quantum Systems, marking a significant milestone in Thüringen's innovation ecosystem.
Target Information
bm|t is a pioneer in identifying innovative founders and companies that are at the forefront of technological advancements. As the organization reflects on the transitions of 2025, it acknowledges the significant progress made within Thüringen's innovation ecosystem, particularly under the leadership of CEO Katja Butzmann, who took on the role in January 2025. With a strong background in the firm since 2016 as both a Senior Investment Manager and CEO, her guidance has been integral during a pivotal year, marked by successful exits and new fund launches that underscore bm|t's commitment to fostering regional economic growth.
One of the most notable achievements of bm|t during this period was the successful acquisition of portfolio company Spleenlab by German defense company Quantum Systems. This acquisition not only reflects the depth of Thüringen’s entrepreneurial landscape but also signifies a strategic alignment that aims to combine elite software and hardware capabilities. Established in Thüringen, Spleenlab is a prime example of the long-term value that bm|t endeavors to create, showcasing the effectiveness of the region’s innovation-driven economy.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Thüringen
Thüringen, located in central Germany, has cultivated a robust technological ecosystem that has witnessed substantial growth in recent years. The region is characterized by a thriving start-up landscape, fueled by supportive economic policies and investment initiati
Similar Deals
Durable Capital Partners, Altimeter Capital, General Catalyst → Parloa
2025
Wolters Kluwer → Libra Technology GmbH
2025
Quantum Systems
invested in
Spleenlab
in 2025
in a Other deal